0.000743421528824304 6.58011620484619E-06 9.87017430728425E-05 -9.87017430728425E-05 -5.92210458436157E-05 -5.92210458436157E-05 -5.92210458436157E-05 -5.92210458436157E-05
Sign Up Today X
Thanks for submitting the form.
Stockreport

Is Regeneron (REGN) Still Attractively Priced After Mixed Recent Share Performance [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
Wondering if Regeneron Pharmaceuticals at around US$764.93 a share still offers value, or if most of the upside is already priced in? This article is designed to help you frame that question clearly. The stock has seen mixed recent returns, with a 0.8% gain over the last 30 days, a 1.5% decline year to date, and a 10.1% return over the past year. These figures can hint at shifting views on both growth potential and risk. Recent news around Regeneron Pharmaceuticals has focused on its position within the broader pharmaceuticals and biotech space, along with investor interest in how its drug portfolio and pipeline support the current share price. These updates are important context when you think about whether the recent 3.5% three year and 63.9% five year returns align with what the company is fundamentally worth today. On Simply Wall St's valuation checks, Regeneron Pharmaceuticals currently scores 5 out of 6 . This suggests several metrics screen as undervalued and sets us up [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

Is Regeneron (REGN) Still Attractively Priced After Mixed Recent Share Performance [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
Wondering if Regeneron Pharmaceuticals at around US$764.93 a share still offers value, or if most of the upside is already priced in? This article is designed to help you frame that question clearly. The stock has seen mixed recent returns, with a 0.8% gain over the last 30 days, a 1.5% decline year to date, and a 10.1% return over the past year. These figures can hint at shifting views on both growth potential and risk. Recent news around Regeneron Pharmaceuticals has focused on its position within the broader pharmaceuticals and biotech space, along with investor interest in how its drug portfolio and pipeline support the current share price. These updates are important context when you think about whether the recent 3.5% three year and 63.9% five year returns align with what the company is fundamentally worth today. On Simply Wall St's valuation checks, Regeneron Pharmaceuticals currently scores 5 out of 6 . This suggests several metrics screen as undervalued and sets us up [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS